Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma

International Journal of Cancer

Volumn 94, Issue 4, 2001, Pages 492-499

  Nies, Anne T ^a   König, Jörg ^a   Pfannschmidt, Marion ^b   Klar, Ernst ^b   Hofmann, Walter J ^b   Keppler, Dietrich ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

ATP dependent transporter; Hepatocellular carcinoma; Immunolocalization; Multidrug resistance; Multidrug resistance protein 2 3

Indexed keywords

ANTINEOPLASTIC AGENT; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL MEMBRANE; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOSINE TRIPHOSPHATE; CARCINOMA, HEPATOCELLULAR; CELL MEMBRANE; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FIBROSIS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; MEMBRANE TRANSPORT PROTEINS; MICROSCOPY, FLUORESCENCE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PHENOTYPE; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0035889601     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1498     Document Type: Article

References (41)

1. Biochemical, cellular and pharmacological aspects of the multidrug transporter
2. Expression of a multidrug resistance gene in human cancers
3. Immunohistochemic study of expression and cellular localization of the multidrug resistance gene product P-glycoprotein in primary liver carcinoma
4. Doxorubicin for unresectable hepatocellular carcinoma. A prospective study on the addition of verapamil
5. Human hepatocellular carcinoma cell lines exhibit multidrug resistance unrelated to MDR1 gene expression
6. Structural, mechanistic and clinical aspects of MRP1
7. Conjugate export pumps of the multidrug resistance protein (MRP) family: Localization, substrate specificity and MRP2-mediated drug resistance
8. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
9. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs
10. r 190,000 multidrug protein, MRP, with monoclonal antibodies
11. Tissue distribution of the multidrug resistance protein
12. Analysis of expression of cMOAT (MRP2), MRP3, MRP4 and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines
13. Conjugate export pumps of the multidrug resistance protein (MRP) family in liver
14. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein. cMRP, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats
15. Congenital jaundice in rats with a mutation in a multidrug resistance associated-protein gene
16. A human canalicular multispecific organic anion transporter (cMOAT) overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation
17. The canalicular conjugate export pump encoded by the cmrp/cmoat gene
18. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells
19. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane
20. MRP3, an organic anion transporter able to transport anti-cancer drugs
21. ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2
22. Location of a protease-hypersensitive region in the multidrug resistance protein (MRP) by mapping of the epitope of MRP-specific monoclonal antibody QCRL-1
23. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome
24. Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies
25. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
26. Treatment of hepatocellular carcinoma
27. Hepatocellular carcinoma
28. Clinical trials in primary hepatocellular carcinoma: Current status and future directions
29. A family of drug transporters: The multidrug resistance-associated proteins
30. 4 express the MRP1 gene-encoded conjugate export pump
31. A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells
32. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA
33. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2
34. 4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2)
35. Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter
36. Vinblastine and sulfinpyra-zone export by the multidrug resistance protein MRP2 is associated with glutathione export
37. Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents
38. Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal-cell carcinoma
39. Transport function and substrate specificity of multidrug resistance protein
40. Characterization of inducible nature of MRP3 in rat liver
41. Inhibitors of MRP1-mediated multidrug resistance